Approval · Notice of Compliance 3500 · 2003
AVANDAMET: Notice of Compliance 3500
Issued November 21, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3500
- Date
- November 21, 2003
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strengths: 2mg/1000mg and 4mg/1000mg
- Therapeutic class
- Antidiabetic agent
Products in this notice
Medicinal ingredients
- METFORMIN HYDROCHLORIDE 1,000 MG per TAB
- ROSIGLITAZONE MALEATE 2 MG per TAB
- ROSIGLITAZONE MALEATE 4 MG per TAB